Memorial Sloan Kettering Cancer Center
Nevenka Dimitrova is a seasoned expert in computational oncology and data science, currently serving as a Computational Oncology Consulting Scientist at Memorial Sloan Kettering Cancer Center since September 2022. Prior to this role, Nevenka held the position of Vice President Data Science and Data Services at GSK, where leadership focused on optimizing data flows for medicinal discovery. Nevenka's extensive experience includes prior roles at Memorial Sloan Kettering as a Visiting Computational Oncology Scientist, a Data Science Advisor at Viome Life Sciences, and Chief Technology Officer at Philips, where innovative strategies in oncology informatics and genomics were implemented. With academic positions as an Adjunct Associate Professor at New York Medical College and Visiting Scientist roles at Cold Spring Harbor Laboratory and Columbia University, Nevenka has contributed to significant research in oncology, immunology, and bioinformatics. Nevenka's educational background includes a PhD and MS in Computer Science from Arizona State University and a B.S. in Mathematics and Computer Science from Univerzitet 'Sv. Kiril i Metódij' vo Skopje.
This person is not in any teams
This person is not in any offices
Memorial Sloan Kettering Cancer Center
9 followers
The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. One of the world’s most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 30 years.